Understanding and harnessing triple-negative breast cancer-related microbiota in oncology.
bacterial theranostics
microbiome
microbiome & dysbiosis
microbiome modulation
triple-negative-breast-cancer
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
15
08
2022
accepted:
31
10
2022
entrez:
12
12
2022
pubmed:
13
12
2022
medline:
13
12
2022
Statut:
epublish
Résumé
Bacterial inhabitants of the body have the potential to play a role in various stages of cancer initiation, progression, and treatment. These bacteria may be distal to the primary tumour, such as gut microbiota, or local to the tissue, before or after tumour growth. Breast cancer is well studied in this context. Amongst breast cancer types, Triple Negative Breast Cancer (TNBC) is more aggressive, has fewer treatment options than receptor-positive breast cancers, has an overall worse prognosis and higher rates of reoccurrence. Thus, an in-depth understanding of the bacterial influence on TNBC progression and treatment is of high value. In this regard, the Gut Microbiota (GM) can be involved in various stages of tumour progression. It may suppress or promote carcinogenesis through the release of carcinogenic metabolites, sustenance of proinflammatory environments and/or the promotion of epigenetic changes in our genome. It can also mediate metastasis and reoccurrence through interactions with the immune system and has been recently shown to influence chemo-, radio-, and immune-therapies. Furthermore, bacteria have also been found to reside in normal and malignant breast tissue. Several studies have now described the breast and breast tumour microbiome, with the tumour microbiota of TNBC having the least taxonomic diversity among all breast cancer types. Here, specific conditions of the tumour microenvironment (TME) - low O2, leaky vasculature and immune suppression - are supportive of tumour selective bacterial growth. This innate bacterial ability could enable their use as delivery agents for various therapeutics or as diagnostics. This review aims to examine the current knowledge on bacterial relevance to TNBC and potential uses while examining some of the remaining unanswered questions regarding mechanisms underpinning observed effects.
Identifiants
pubmed: 36505861
doi: 10.3389/fonc.2022.1020121
pmc: PMC9730816
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1020121Informations de copyright
Copyright © 2022 Devoy, Flores Bueso and Tangney.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nihon Rinsho. 2008 Jun;66(6):1211-8
pubmed: 18540373
Cancers (Basel). 2019 Nov 20;11(12):
pubmed: 31756919
Bioeng Bugs. 2010 Nov-Dec;1(6):385-94
pubmed: 21468205
Cancer Discov. 2018 Apr;8(4):403-416
pubmed: 29567829
Nutr Cancer. 2022;74(3):938-946
pubmed: 34192986
Biomark Insights. 2022 Feb 22;17:11772719221078774
pubmed: 35221668
Cell Host Microbe. 2018 Jun 13;23(6):716-724
pubmed: 29902437
Mol Cell Ther. 2014 Sep 10;2:27
pubmed: 26056594
Science. 2021 Feb 5;371(6529):602-609
pubmed: 33303685
J Control Release. 2016 Jan 28;222:9-17
pubmed: 26655063
Nat Metab. 2021 Feb;3(2):274-286
pubmed: 33619379
Int Rev Immunol. 2011 Feb;30(1):16-34
pubmed: 21235323
Int J Mol Sci. 2019 May 16;20(10):
pubmed: 31100929
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3457-62
pubmed: 25737556
PLoS One. 2014 Jan 08;9(1):e83744
pubmed: 24421902
Cancer Lett. 2019 Apr 10;447:41-47
pubmed: 30684593
Front Immunol. 2020 Jan 17;10:2989
pubmed: 32010123
Gastroenterol Hepatol (N Y). 2013 Sep;9(9):560-9
pubmed: 24729765
World J Gastroenterol. 2015 Aug 7;21(29):8787-803
pubmed: 26269668
Cancer Manag Res. 2022 Jan 03;14:1-17
pubmed: 35018117
Perm J. 2020;24:
pubmed: 32589577
Front Pharmacol. 2015 Nov 10;6:272
pubmed: 26617524
Oncotarget. 2016 Mar 22;7(12):13599-611
pubmed: 26871946
Science. 2004 Mar 12;303(5664):1662-5
pubmed: 15016999
Lancet. 1999 May 15;353(9165):1689-94
pubmed: 10335805
Breast Cancer. 2006;13(1):27-31
pubmed: 16518059
Iran J Pharm Res. 2019 Fall;18(Suppl1):31-50
pubmed: 32802088
Nature. 2019 Jan;565(7741):600-605
pubmed: 30675064
Oncoimmunology. 2017 Feb 6;6(2):e1253654
pubmed: 28344865
Mol Ther. 2010 Jul;18(7):1397-407
pubmed: 20389288
J Hematol Oncol. 2022 Aug 29;15(1):121
pubmed: 36038913
Cancer Res. 2002 May 1;62(9):2455-61
pubmed: 11980632
Discov Med. 2018 Sep;26(142):93-102
pubmed: 30399327
Genome Med. 2021 Apr 16;13(1):60
pubmed: 33863341
Nat Commun. 2020 Jun 26;11(1):3259
pubmed: 32591509
Genes Dev. 2018 Oct 1;32(19-20):1267-1284
pubmed: 30275043
Mol Med Rep. 2018 Sep;18(3):3411-3420
pubmed: 30066873
Maturitas. 2018 Jun;112:53-63
pubmed: 29704918
J Agric Food Chem. 2005 Aug 10;53(16):6281-8
pubmed: 16076107
Front Microbiol. 2018 May 15;9:951
pubmed: 29867857
Ann Oncol. 2014 Aug;25(8):1544-50
pubmed: 24608200
Cell. 2021 Jun 24;184(13):3394-3409.e20
pubmed: 34077752
J Natl Cancer Inst. 2015 Mar 30;107(6):djv048
pubmed: 25825511
Microbiome. 2020 May 20;8(1):69
pubmed: 32434586
J Biol Chem. 2003 Jul 11;278(28):25481-9
pubmed: 12711604
Int J Mol Sci. 2019 Jan 14;20(2):
pubmed: 30646517
Front Oncol. 2021 Apr 15;11:626349
pubmed: 33937029
Lipids Health Dis. 2017 Nov 2;16(1):208
pubmed: 29096636
Trends Cancer. 2019 Nov;5(11):670-676
pubmed: 31735286
Food Chem Toxicol. 2008 Apr;46(4):1221-9
pubmed: 17942208
Sci Rep. 2021 Sep 17;11(1):18535
pubmed: 34535726
Science. 2012 Jun 8;336(6086):1262-7
pubmed: 22674330
Annu Rev Nutr. 2008;28:347-66
pubmed: 18598138
Trends Biochem Sci. 2016 Mar;41(3):211-218
pubmed: 26778478
Biomedicines. 2022 Jan 27;10(2):
pubmed: 35203499
Sci Transl Med. 2016 Oct 19;8(361):361ra138
pubmed: 27798263
PLoS One. 2010 May 26;5(5):e10850
pubmed: 20520770
Microbiome. 2020 Aug 22;8(1):122
pubmed: 32828122
Front Mol Biosci. 2022 Jan 25;9:836417
pubmed: 35145999
Nat Biotechnol. 2020 Nov;38(11):1288-1297
pubmed: 32541956
Cancers (Basel). 2019 Aug 27;11(9):
pubmed: 31461945
Curr Opin Immunol. 1997 Feb;9(1):4-9
pubmed: 9039775
Oncogene. 2015 Jul 30;34(31):4130-41
pubmed: 25347741
Nature. 2017 Nov 30;551(7682):648-652
pubmed: 29168502
Oncogene. 2007 Aug 13;26(37):5420-32
pubmed: 17694083
Breast Cancer Res Treat. 2008 Jul;110(1):9-17
pubmed: 17674188
Front Immunol. 2018 Oct 16;9:2379
pubmed: 30459758
Oncology (Williston Park). 2002 Feb;16(2):217-26, 229; discussion 230-2
pubmed: 11866137
Science. 2017 Dec 15;358(6369):1443-1448
pubmed: 29170280
Pediatrics. 2007 Mar;119(3):e724-32
pubmed: 17332189
Sci Rep. 2016 Aug 03;6:30751
pubmed: 27485780
Nat Commun. 2015 Oct 27;6:8746
pubmed: 26503059
PLoS One. 2016 Jun 16;11(6):e0157368
pubmed: 27310713
Biochim Biophys Acta Bioenerg. 2018 Sep;1859(9):958-974
pubmed: 29655782
Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):1034-1043
pubmed: 29485045
Eur Urol. 2017 Oct;72(4):625-631
pubmed: 28434677
Lancet. 1994 Mar 12;343(8898):633-5
pubmed: 7906811
Nature. 2016 Apr 14;532(7598):245-9
pubmed: 27049944
Int J Cancer. 2003 Apr 20;104(4):488-95
pubmed: 12584748
Front Oncol. 2019 Jul 18;9:596
pubmed: 31380268
Front Nutr. 2019 Feb 25;6:16
pubmed: 30859104
Oncotarget. 2017 May 30;8(22):36225-36245
pubmed: 28410234
Appl Environ Microbiol. 2016 Jul 29;82(16):5039-48
pubmed: 27342554
Oncotarget. 2018 Apr 3;9(25):17915-17927
pubmed: 29707157
Sci Rep. 2019 Feb 4;9(1):1300
pubmed: 30718646
Int J Mol Sci. 2019 Nov 23;20(23):
pubmed: 31771178
Pharmacol Res. 2020 Oct;160:105072
pubmed: 32679181
Proc Natl Acad Sci U S A. 2021 Jun 22;118(25):
pubmed: 34161260
Annu Rev Pathol. 2022 Jan 24;17:181-204
pubmed: 35073169
Cancer Manag Res. 2019 Sep 23;11:8571-8575
pubmed: 31576164
Biomed Pharmacother. 2021 Jul;139:111619
pubmed: 33906079
Sci Rep. 2015 Oct 15;5:15162
pubmed: 26469225
Cancer Sci. 2006 Jul;97(7):649-57
pubmed: 16827806
Nat Rev Gastroenterol Hepatol. 2017 Sep;14(9):527-539
pubmed: 28676707
Cells. 2019 Dec 15;8(12):
pubmed: 31847455
J Agric Food Chem. 2012 Nov 14;60(45):11301-8
pubmed: 23113683
Radiat Res. 1964 Nov;23:333-49
pubmed: 14229117
J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):89-96
pubmed: 17113977
Cancer Treat Res. 2019;178:253-264
pubmed: 31209849
Gut. 2021 Jun;70(6):1174-1182
pubmed: 33272977
Biochem J. 2017 May 16;474(11):1823-1836
pubmed: 28512250
Immune Netw. 2018 Aug 13;18(4):e27
pubmed: 30181915
Breast Cancer Res Treat. 2018 Feb;167(3):671-686
pubmed: 29063313
Cell. 2014 Mar 27;157(1):121-41
pubmed: 24679531
Front Immunol. 2021 Apr 22;12:673708
pubmed: 33968085
J Clin Endocrinol Metab. 2014 Dec;99(12):4632-40
pubmed: 25211668
Front Oncol. 2020 Feb 12;10:120
pubmed: 32117767
Carcinogenesis. 2009 Jul;30(7):1073-81
pubmed: 19468060
Microbiome. 2018 May 22;6(1):92
pubmed: 29789015
Front Cell Dev Biol. 2022 Apr 14;10:880544
pubmed: 35493075
Int J Mol Sci. 2020 Jan 08;21(2):
pubmed: 31936237
In Vitro Cell Dev Biol Anim. 2016 Mar;52(3):337-348
pubmed: 26659392
Integr Med (Encinitas). 2018 Aug;17(4):28-32
pubmed: 31043907
Curr Nutr Food Sci. 2013 Aug;9(3):194-200
pubmed: 23966890
Nature. 2017 Oct 5;550(7674):61-66
pubmed: 28953883
J Exp Clin Cancer Res. 2021 Jan 25;40(1):42
pubmed: 33494784
Science. 2020 May 29;368(6494):973-980
pubmed: 32467386
Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:1-13
pubmed: 2700931
Front Oncol. 2020 Jul 07;10:902
pubmed: 32733788
Int J Mol Sci. 2022 Jan 22;23(3):
pubmed: 35163143
Cell Death Differ. 2021 Sep;28(9):2778-2796
pubmed: 33963313
Immunobiology. 2005;210(5):349-58
pubmed: 16164041
Trends Cancer. 2021 May;7(5):447-464
pubmed: 33303401
Cancers (Basel). 2018 Mar 20;10(3):
pubmed: 29558443
JAMA. 2004 Feb 18;291(7):827-35
pubmed: 14970061
Cancers (Basel). 2018 Dec 14;10(12):
pubmed: 30558195
Infect Agent Cancer. 2013 Mar 28;8(1):11
pubmed: 23537317
Nat Rev Clin Oncol. 2019 Sep;16(9):563-580
pubmed: 31092901
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4130-5
pubmed: 15024130
Curr Opin Immunol. 2018 Oct;54:137-144
pubmed: 30205357
Cell Death Dis. 2019 Nov 7;10(11):849
pubmed: 31699962
Nat Immunol. 2001 Apr;2(4):361-7
pubmed: 11276208
Curr Oncol. 2022 Jul 07;29(7):4768-4778
pubmed: 35877238
PLoS One. 2017 Nov 30;12(11):e0188873
pubmed: 29190829
Clin Cancer Res. 2019 Nov 1;25(21):6487-6500
pubmed: 31345839
Int J Mol Sci. 2019 Aug 25;20(17):
pubmed: 31450712
J Biol Chem. 2017 May 26;292(21):8569-8576
pubmed: 28389557
Front Microbiol. 2021 Dec 15;12:797445
pubmed: 34975821
Nutr Rev. 2012 Aug;70 Suppl 1:S38-44
pubmed: 22861806
Int J Mol Sci. 2020 Dec 21;21(24):
pubmed: 33371435
Cancer Res. 2011 Apr 1;71(7):2466-75
pubmed: 21427357
Front Oncol. 2022 May 26;12:869078
pubmed: 35692755
Clin Cancer Res. 2012 Feb 1;18(3):858-68
pubmed: 22147941
Science. 2018 Jan 5;359(6371):104-108
pubmed: 29302014
J Mol Biol. 2015 Oct 23;427(21):3389-406
pubmed: 26156863
PLoS One. 2017 Oct 19;12(10):e0186334
pubmed: 29049318
Front Nutr. 2019 Apr 17;6:45
pubmed: 31058158
Microb Ecol Health Dis. 2015 Feb 02;26:26050
pubmed: 25651996
Nature. 2012 Sep 13;489(7415):220-30
pubmed: 22972295
Science. 2015 Nov 27;350(6264):1084-9
pubmed: 26541606
J Clin Invest. 2020 Jan 2;130(1):466-479
pubmed: 31815742
Science. 2018 Jan 5;359(6371):97-103
pubmed: 29097493
Science. 2021 Feb 5;371(6529):595-602
pubmed: 33542131
Int J Syst Evol Microbiol. 2008 May;58(Pt 5):1221-7
pubmed: 18450717
Nature. 2020 Jan;577(7792):S6-S8
pubmed: 31996823
Cell Death Dis. 2021 Sep 4;12(9):831
pubmed: 34482363
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):E9580-E9589
pubmed: 30257941
Int J Cancer. 2021 Apr 1;148(7):1708-1716
pubmed: 33285000
CA Cancer J Clin. 2017 Jul 8;67(4):326-344
pubmed: 28481406
Nature. 2012 Aug 9;488(7410):178-84
pubmed: 22797518
NPJ Breast Cancer. 2022 Feb 17;8(1):20
pubmed: 35177654
J Cancer Res Clin Oncol. 2017 Sep;143(9):1637-1647
pubmed: 28409272
J Clin Invest. 2000 Apr;105(8):1027-30
pubmed: 10772643
Vaccine. 2009 Jun 19;27(30):3975-83
pubmed: 19389451
Int J Mol Sci. 2020 Dec 03;21(23):
pubmed: 33287442
Periodontol 2000. 2006;42:114-57
pubmed: 16930309
Biomolecules. 2021 Nov 29;11(12):
pubmed: 34944428
Sci Rep. 2015 Sep 29;5:14554
pubmed: 26416623
Appl Environ Microbiol. 2008 Aug;74(15):4650-5
pubmed: 18539795
J Cell Biochem. 2005 May 1;95(1):131-8
pubmed: 15723291
J Appl Microbiol. 2006 Sep;101(3):571-8
pubmed: 16907807
Front Immunol. 2020 Jun 09;11:906
pubmed: 32582143
Front Oncol. 2022 Jun 30;12:830894
pubmed: 35847875
Aliment Pharmacol Ther. 2014 Sep;40(5):409-21
pubmed: 25040088
Sci Transl Med. 2014 Aug 13;6(249):249ra111
pubmed: 25122639
Nature. 2005 Jun 9;435(7043):752-3
pubmed: 15944689
Cells. 2020 Oct 26;9(11):
pubmed: 33114740
J Immunother Cancer. 2019 Apr 17;7(1):108
pubmed: 30995949
Neurosci Insights. 2021 May 27;16:26331055211018709
pubmed: 34104888
Cancer J. 2014 May-Jun;20(3):181-9
pubmed: 24855005
Trends Mol Med. 2015 Feb;21(2):109-17
pubmed: 25578246
Signal Transduct Target Ther. 2021 Aug 4;6(1):291
pubmed: 34344870
J Oral Maxillofac Surg. 2006 Jun;64(6):969-71
pubmed: 16713816
Clin Infect Dis. 2016 Mar 1;62(5):568-573
pubmed: 26611780
Cell Host Microbe. 2013 Aug 14;14(2):207-15
pubmed: 23954159
J Lipid Res. 2013 Sep;54(9):2325-40
pubmed: 23821742
PLoS Biol. 2016 Aug 19;14(8):e1002533
pubmed: 27541692
Ann Oncol. 2017 Jun 01;28(6):1368-1379
pubmed: 28368458
Science. 2015 Nov 27;350(6264):1079-84
pubmed: 26541610
Cureus. 2021 Aug 26;13(8):e17472
pubmed: 34513524
Science. 2018 Jan 5;359(6371):91-97
pubmed: 29097494
Clin Infect Dis. 2010 Jun 15;50(12):1551-8
pubmed: 20455694
Breast. 2022 Sep 2;66:15-23
pubmed: 36084384
Int J Cancer. 2014 Aug 1;135(3):529-40
pubmed: 24382758
Cell Physiol Biochem. 2019;52(3):468-485
pubmed: 30873822
Acta Pharm Sin B. 2015 Mar;5(2):99-105
pubmed: 26579434
J Cancer. 2018 Jun 15;9(14):2510-2517
pubmed: 30026849
EMBO Mol Med. 2017 Apr;9(4):448-461
pubmed: 28242755
Nat Rev Cancer. 2013 Nov;13(11):800-12
pubmed: 24132111
Ann Afr Med. 2019 Jul-Sep;18(3):121-126
pubmed: 31417011
Nutrients. 2019 Sep 16;11(9):
pubmed: 31527435
Mol Aspects Med. 2017 Aug;56:54-65
pubmed: 28602676
Nat Rev Cancer. 2010 Nov;10(11):785-94
pubmed: 20944664
Cancer Discov. 2022 Jan;12(1):31-46
pubmed: 35022204
J Immunol Res. 2020 Dec 8;2020:5618786
pubmed: 33457427
Neoplasia. 2017 Oct;19(10):848-855
pubmed: 28923537
J Leukoc Biol. 2016 Nov;100(5):865-879
pubmed: 27605211
Curr Gene Ther. 2010 Feb;10(1):3-14
pubmed: 20156191
Molecules. 2021 Jul 21;26(15):
pubmed: 34361566
Cancer Metastasis Rev. 2021 Dec;40(4):1223-1249
pubmed: 34967927
Sci Rep. 2020 Oct 1;10(1):16356
pubmed: 33004967
Oncol Rev. 2019 Sep 27;13(2):422
pubmed: 31583054
Oncologist. 2017 Jun;22(6):627-630
pubmed: 28576858
Cancers (Basel). 2011 Jun 21;3(2):2734-49
pubmed: 24212830
Microb Cell Fact. 2021 Feb 5;20(1):36
pubmed: 33546705
Clin Gastroenterol Hepatol. 2019 Jan;17(2):290-295
pubmed: 30144522
Front Oncol. 2020 Feb 21;10:179
pubmed: 32154174
Br J Nutr. 2010 Jul;104(2):227-32
pubmed: 20193099
Cell Microbiol. 2014 Jul;16(7):1024-33
pubmed: 24798552
mBio. 2020 Mar 10;11(2):
pubmed: 32156803
Front Oncol. 2021 Oct 28;11:742139
pubmed: 34778059
Genes Dev. 2016 Jul 15;30(14):1589-97
pubmed: 27474437
Nutrients. 2021 Oct 19;13(10):
pubmed: 34684657
Oncotarget. 2017 Aug 14;8(50):88122-88138
pubmed: 29152146
J Leukoc Biol. 2007 Jan;81(1):1-5
pubmed: 17032697
Nature. 2021 Apr;592(7852):138-143
pubmed: 33731925
Environ Microbiol. 2012 Aug;14(8):1876-87
pubmed: 22364273
Nat Rev Immunol. 2019 Mar;19(3):184-197
pubmed: 30718831
Sci Rep. 2019 Jan 28;9(1):801
pubmed: 30692549
Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2102-6
pubmed: 17119034
Science. 2017 Sep 15;357(6356):1156-1160
pubmed: 28912244
Biol Methods Protoc. 2020 Jul 27;5(1):bpaa015
pubmed: 33072872
PLoS One. 2015 May 08;10(5):e0126312
pubmed: 25955845
Appl Environ Microbiol. 2014 May;80(10):3007-14
pubmed: 24610844
Nat Med. 2013 May;19(5):576-85
pubmed: 23563705
Explor Target Antitumor Ther. 2022;3(1):27-36
pubmed: 36046357
PLoS One. 2011;6(6):e21313
pubmed: 21695057
Science. 2013 Nov 22;342(6161):967-70
pubmed: 24264989
Front Immunol. 2018 Aug 07;9:1596
pubmed: 30131800
Nat Rev Immunol. 2020 Jan;20(1):40-54
pubmed: 31388093
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4539-46
pubmed: 20615998
JCO Glob Oncol. 2021 Jul;7:1129-1140
pubmed: 34264759